New York S05580 requires the commissioner of health to create and publish a list of generic drug products.
New York S05580 mandates the commissioner of health to establish and publish a list of generic drug products. This list will include drug products approved by the Federal Food and Drug Administration as safe and effective, and those listed on the approved drug products list. The commissioner must make available to the public the studies and summaries provided by manufacturers, including bioequivalence data and adverse event incidence. The bill also repeals a previous provision that allowed for the substitution of generic drugs unless the prescriber specifically indicated otherwise.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.